(Image source: techcrunch) Diabetes all around the world should rejoice with Google Inc’s (NASDAQ:GOOG) initiative. Google is in the process of testing smart contact lens that would measure glucose levels through tears and generate readings in matters of seconds. If the prototype become operational and gains FDA approval, it would mean no more needles for diabetes.Microsoft Corporation (NASDAQ:MSFT) had a similar initiative back in 2011, but it never took off. If anybody could do it, Google is a sure bet. The tech giant is current seeking partners that know something about taking similar products to market.